NCT03144804 2024-06-06
A Phase 2 Study of Lamivudine in Patients With p53 Mutant Metastatic Colorectal Cancer
Massachusetts General Hospital
Phase 2 Completed
Massachusetts General Hospital
Seoul National University Hospital
AIDS Malignancy Consortium